Skip to main content
OpenTrials

Clinical trial condition

Eye Diseases

Explore clinical trials studying Eye Diseases. Study availability and eligibility vary by location and protocol.

10,583 public trials 1,307 recruiting studies
Refine in advanced search Browse all conditions

Eye Diseases trial results

Completed

A Phase 1, Open-Label Study of Latanoprost Acid Plasma Concentrations in Pediatric and Adult Glaucoma Patients Treated With Latanoprost.

NCT00638742

Conditions
Eye Diseases, Glaucoma, Ocular Hypertension
Locations
  • Pfizer Investigational Site Artesia, California, United States
  • Pfizer Investigational Site Atlanta, Georgia, United States
  • Pfizer Investigational Site Atlanta, Georgia, United States
  • Pfizer Investigational Site North Dartmouth, Massachusetts, United States
View all 13 locations
View Trial Details
Completed

A Study Comparing The Efficacy, Safety And Tolerability Of Latanoprost 75, 100 And 125 ug/ml To Xalatan In The Treatment Of Primary Open-Angle Glaucoma And Ocular Hypertension

NCT01379144

Conditions
Eye Diseases, Glaucoma, Glaucoma, Open-Angle, +2 more
Locations
  • Eye Associates Pty Limited Sydney, New South Wales, Australia
  • Save Sight Institute Sydney, New South Wales, Australia
  • Royal Adelaide Hospital, North Terrace Adelaide, South Australia, Australia
  • University Hospital Brno-Bohunice Brno, Czechia
View all 25 locations
View Trial Details
Completed

A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within the United Kingdom

NCT00751049

Conditions
Eye Diseases, Glaucoma, Glaucoma, Open-Angle, +2 more
Locations
  • Pfizer Investigational Site Aberdeen, Grampian, United Kingdom
  • Pfizer Investigational Site Nottingham, Notts., United Kingdom
  • Pfizer Investigational Site Bristol, United Kingdom
  • Pfizer Investigational Site Cambridge, United Kingdom
View Trial Details
Completed

Distribution of Risk Factors in Ocular Hypertension and Open-Angle Glaucoma Patients in Canada

NCT00334750

Conditions
Eye Diseases, Glaucoma, Glaucoma, Open-Angle, +1 more
Locations
  • Pfizer Investigational Site Calgary, Alberta, Canada
  • Pfizer Investigational Site Edmonton, Alberta, Canada
  • Pfizer Investigational Site Edmonton, Alberta, Canada
  • Pfizer Investigational Site Nanaimo, British Columbia, Canada
View all 21 locations
View Trial Details
Completed

Comparison of Latanoprost With Travoprost and Bimatoprost in Patients With Elevated IOP. A 12-weeks, Masked Evaluator, Phase IV Multi-center Study in the US

NCT00847483

Conditions
Eye Diseases, Glaucoma, Ocular Hypertension
Locations
  • Pfizer Investigational Site Bellflower, California, United States
  • Pfizer Investigational Site Inglewood, California, United States
  • Pfizer Investigational Site San Diego, California, United States
  • Pfizer Investigational Site San Diego, California, United States
View all 40 locations
View Trial Details
Completed

A Study to Assess Whether PDE5 Inhibitors Increase the Chance of Triggering the Onset of Acute NAION

NCT00759174

Conditions
Cardiovascular Diseases, Cranial Nerve Diseases, Eye Diseases, +4 more
Locations
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Mobile, Alabama, United States
  • Pfizer Investigational Site Anchorage, Alaska, United States
  • Pfizer Investigational Site Little Rock, Arkansas, United States
View all 105 locations
View Trial Details
Completed

Safety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation

NCT02163824

Conditions
Cataract, Eye Diseases, Eye Infections, +9 more
Locations
  • Sall Research Medical Center Artesia, California, United States
  • North Valley Eye Medical Group Mission Hills, California, United States
  • Martel Eye Medical Group Rancho Cordova, California, United States
  • Wolstan & Goldberg Eye Associates Torrance, California, United States
View all 23 locations
View Trial Details

Related conditions